Home Biosimilar Antibodies Others Others antibody Emicizumab (Anti-F9 / Factor IX) For research use only.
Not for use in humans.

Emicizumab (Anti-F9 / Factor IX)

Synonyms:

Emicizumab (Anti-F9 / Factor IX) is a bispecific monoclonal antibody that bridges activated factor IX and factor X to replace the function of missing activated factor VIII, thereby restoring hemostasis. Emicizumab can be used for hemophilia A research. MW: 145.5 KD.

Emicizumab (Anti-F9 / Factor IX)

Purity & Quality Control

≥99

Biological Activity

Description Emicizumab (Anti-F9 / Factor IX) is a bispecific monoclonal antibody that bridges activated factor IX and factor X to replace the function of missing activated factor VIII, thereby restoring hemostasis. Emicizumab can be used for hemophilia A research. MW: 145.5 KD.

Product Details

CAS No. 1610943-06-0
Molecular Weight 145.5 kDa
Isotype Human IgG4SP
Source CHO
Purification AKTA
Sterility 0.2 μM filtered
Formulation 100mMPro-Ac,20mMArg-Ac，pH5.0
Storage
(From the date of receipt)		 Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.

Tech Support

If you have any other enquiries, please leave a message.

* Indicates a Required Field

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.
Tags: buy Emicizumab (Anti-F9 / Factor IX) | Emicizumab (Anti-F9 / Factor IX) supplier | purchase Emicizumab (Anti-F9 / Factor IX) | Emicizumab (Anti-F9 / Factor IX) cost | Emicizumab (Anti-F9 / Factor IX) manufacturer | order Emicizumab (Anti-F9 / Factor IX) | Emicizumab (Anti-F9 / Factor IX) distributor